NCT05048784 A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants Status COMPLETED Phase PHASE1
NCT05045638 Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT05032066 A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT05002998 TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study Status COMPLETED Phase PHASE4
NCT04998747 A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Status WITHDRAWN Phase PHASE1
NCT04994717 Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04987333 Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants Status COMPLETED Phase PHASE1
NCT04987320 A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) Status COMPLETED Phase PHASE1
NCT04987307 Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT04956809 Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure Status COMPLETED Phase PHASE2
NCT04951856 Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04948099 A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases Status COMPLETED Phase PHASE1
NCT04933942 Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma Status WITHDRAWN Phase PHASE2
NCT04933695 A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment Status TERMINATED Phase PHASE2
NCT04925934 Study of VIB7734 for the Treatment of Moderate to Severely Active SLE Status COMPLETED Phase PHASE2
NCT04887064 Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment Status COMPLETED Phase PHASE1
NCT04885998 AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) Status COMPLETED Phase PHASE1
NCT04884763 Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder Status COMPLETED Phase PHASE2